Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Collaborative drug discovery for More Medicines for Tuberculosis (MM4TB)

Published:2017-03 Issue:3 Volume:22 Page:555-565
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Ekins Sean,Spektor Anna Coulon,Clark Alex M.,Dole Krishna,Bunin Barry A.

Funder

European Community's Seventh Framework Program

National Institutes of Allergy and Infectious Diseases

NIH NCATS

Bill and Melinda Gates Foundation

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference105 articles.

1. Drug discovery and repurposing at Memorial Sloan Kettering Cancer Center: chemical biology drives translational medicine;Bhinder;ACS Chem. Biol.,2014

2. Collaboration versus outsourcing: the need to think outside the box;Robertson;Future Med. Chem.,2011

3. Precarious connections: making therapeutic production happen for malaria and tuberculosis;Craddock;Soc. Sci. Med.,2015

4. Grants4Targets: an open innovation initiative to foster drug discovery collaborations;Dorsch;Nat. Rev. Drug Discov.,2015

5. Racing to define pharmaceutical R&D external innovation models;Wang;Drug Discov. Today,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning approaches in diagnosing tuberculosis through biomarkers - A systematic review;Progress in Biophysics and Molecular Biology;2023-05

2. NTD Health: an electronic medical record system for neglected tropical diseases;Biomédica;2022-12-01

3. The Current Perspectives in Clinical Research: Computer-Assisted Drug Designing, Ethics, and Good Clinical Practice;Borneo Journal of Pharmacy;2022-05-31

4. Big data and machine learning for materials science;Discover Materials;2021-04-19

5. Bioprospecting for Antibacterial Drugs: a Multidisciplinary Perspective on Natural Product Source Material, Bioassay Selection and Avoidable Pitfalls;Pharmaceutical Research;2020-06-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3